Literature DB >> 16750932

Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.

Sunan Nakornchai1, Phattanapong Konthiang.   

Abstract

Chlorpheniramine, a histamine H1 receptor antagonist, was assayed for in vitro antimalarial activity against multidrug-resistant Plasmodium falciparum K1 strain and chloroquine-resistant P. falciparum T9/94 clone, by measuring the 3H-hypoxanthine incorporation. Chlorphenirame inhibited P. falciparum K1 and T9/94 growth with IC50 values of 136.0+/-40.2 microM and 102.0+/-22.6 microM respectively. A combination of antimalarial drug and chlorpheniramine was tested against resistant P. falciparum in vitro. Isobologram analysis showed that chlorpheniramine exerts marked synergistic action on chloroquine against P. falciparum K1 and T9/94. Chlorpheniramine also potentiated antimalarial action of mefloquine, quinine or pyronaridine against both of the resistant strains of P. falciparum. However, chlorpheniramine antagonism with artesunate was obtained in both P. falciparum K1 and T9/94. The results in this study indicate that antihistaminic drugs may be promising candidates for potentiating antimalarial drug action against drug resistant malarial parasites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750932     DOI: 10.1016/j.parint.2005.11.058

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  5 in total

1.  Chlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT.

Authors:  Karen J Deane; Robert L Summers; Adele M Lehane; Rowena E Martin; Russell A Barrow
Journal:  ACS Med Chem Lett       Date:  2014-03-03       Impact factor: 4.345

2.  In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine.

Authors:  Marcus R Pereira; Philipp P Henrich; Amar Bir Singh Sidhu; David Johnson; Joel Hardink; Jeffrey Van Deusen; Jian Lin; Katrina Gore; Connor O'Brien; Mamadou Wele; Abdoulaye Djimde; Richa Chandra; David A Fidock
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

3.  Phase I/II evaluation of the prophylactic antimalarial activity of pafuramidine in healthy volunteers challenged with Plasmodium falciparum sporozoites.

Authors:  Myaing M Nyunt; Craig W Hendrix; Rahul P Bakshi; Nirbhay Kumar; Theresa A Shapiro
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

4.  Joining forces: Leveraging novel combination therapies to combat infections with eukaryotic pathogens.

Authors:  Rachel E Ham; Lesly A Temesvari
Journal:  PLoS Pathog       Date:  2020-12-31       Impact factor: 6.823

5.  Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease.

Authors:  Walid Beghdadi; Adeline Porcherie; Bradley S Schneider; David Dubayle; Roger Peronet; Michel Huerre; Takeshi Watanabe; Hiroshi Ohtsu; Jacques Louis; Salaheddine Mécheri
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.